Publicaciones Científicas

Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants

NCD Risk Factor Collaboration (NCD-RisC), Rubinstein A. Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants. Lancet. 2024;404(10467):2077-93.

Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants Ver más »

General and abdominal adiposity and hypertension in eight world regions: a pooled analysis of 837 population-based studies with 7·5 million participants

NCD Risk Factor Collaboration (NCD-RisC), Rubinstein A. General and abdominal adiposity and hypertension in eight world regions: a pooled analysis of 837 population-based studies with 7·5 million participants. Lancet. 2024;404(10455):851-63.

General and abdominal adiposity and hypertension in eight world regions: a pooled analysis of 837 population-based studies with 7·5 million participants Ver más »

Population confidence in the health system in 15 countries: results from the first round of the People’s Voice Survey

Kruk ME, Kapoor NR, Lewis TP, Arsenault C, Boutsikari EC, Breda J, et al. Population confidence in the health system in 15 countries: results from the first round of the People's Voice Survey. Lancet Glob Health. 2024;12(1):e100-e11.

Population confidence in the health system in 15 countries: results from the first round of the People’s Voice Survey Ver más »

INEAS’s Cost-Effectiveness Analysis of Vemurafenib: Paving the Way for Value-Based Pricing in Tunisia

Jameleddine M, Harzallah N, Grati H, Odabachian Jebali MC, Chemli J, García Martí S, et al. INEAS's Cost-Effectiveness Analysis of Vemurafenib: Paving the Way for Value-Based Pricing in Tunisia. J Mark Access Health Policy. 2024;12(4):294-305.

INEAS’s Cost-Effectiveness Analysis of Vemurafenib: Paving the Way for Value-Based Pricing in Tunisia Ver más »

Reduction in the incidence of invasive infections caused by encapsulated bacteria after the onset of the COVID-19 pandemic

Guzzi L, Sambade JM, Christin MD, Rodriguez Cairoli F, Rodriguez A, Vicario S, et al. Reduction in the incidence of invasive infections caused by encapsulated bacteria after the onset of the COVID-19 pandemic. Rev Argent Microbiol. 2024;56(1):62-8.

Reduction in the incidence of invasive infections caused by encapsulated bacteria after the onset of the COVID-19 pandemic Ver más »

A Multi-Component Intervention to Improve Therapeutic Adherence in Uncontrolled Hypertensive Patients Within the Primary Care Level: A Before-and-After Study

Gulayin P, Gutierrez L, Pinto D, Fontana S, Ávila M, Gómez W, et al. A Multi-Component Intervention to Improve Therapeutic Adherence in Uncontrolled Hypertensive Patients Within the Primary Care Level: A Before-and-After Study. High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension. 2024;31.

A Multi-Component Intervention to Improve Therapeutic Adherence in Uncontrolled Hypertensive Patients Within the Primary Care Level: A Before-and-After Study Ver más »